Global Commercial Director, Breast Cancer Launches

ROLE SUMMARY

At Pfizer Oncology, we are committed to “Outdo Cancer” by advancing transformative medicines wherever we can make a profound difference in the lives of patients. Today, Pfizer Oncology has an industry-leading pipeline that includes a portfolio across breast, genitourinary (GU), hematology-oncology and Precision Medicine areas.

On the heels of our success with IBRANCE, the growing Breast Cancer portfolio continues to accelerate with the development of multiple assets, including our KAT6 inhibitor, prifetrastat, and next generation CDK4 inhibitor, atirmociclib.

This is a leadership role that requires developing and implementing market winning launch strategies in an increasingly crowded market. The position commands a candidate with strong cross functional leadership who can be a change agent for the next wave of breast cancer launches.

Champion and synthesize customer insights and translate key critical insights into Global strategy and action plans. Lead the development and implementation of key strategic initiatives working closely with US and ex-US colleagues, cross-functional partners in Medical, Legal, Regulatory, GASP, and Business Analytics.

Launch Leadership

• Co-lead the launch strategy for atirmociclib in 1L HR+/HER2- breast cancer

• Drive differentiation of CDK4 in an established, mature CDK 4/6 market

• Advance co-positioning of breast cancer assets and indications across the portfolio

• Go-to-market redesign: partner with regions and countries to upgrade the GTM model to one that embraces and leverages the role of AI across key customer segments, Physicians, Patients, and Caregivers

CDK4 Market Development

• Design and launch the CDK4 Global Market Development Plan for atirmociclib. Drive coordination of the market development strategy (in partnership with prifetrastat) at the global, regional and local levels and ensure consistency of approach and implementation

• Set market development engagement priorities by stakeholder (HCP/Oncology/Urology/Nurses/Payers and Patients)

• Define market development success metrics and KPIs for tracking impact and progress

• Manage agency and vendor partnership efforts pertaining to the design, development and execution of all critical market development assets

Portfolio Operating Plan Lead

• Lead Breast Cancer Pipeline and Launches Operating Plan

• Drive three-year tactical plan development across the portfolio

• Align both the strategic and tactical plan across the global team, regional teams, and cross functional partners

Portfolio Competitive Intelligence Lead

• Competitive Intelligence Lead across BC Launches team: prifetrastat and atirmociclib

• Elevate key competitor insights, breaking news, and implications

• Lead strategic response to CI developments

BC Launches Narrative

• Co-lead positioning narrative across brands and lines of therapy

• Support portfolio communications geared towards executive leadership

Atirmociclib Patient Lead

• Develop and lead strategic framework for global patient communications

• Distill patient insights into an actionable platform across both biomarker testing and branded product information

 Conducts all activities and makes decisions that are in accordance with Company policies & SOPs, Pfizer values & global regulatory guidelines

BASIC QUALIFICATIONS

• Bachelor’s degree

• 8+ years commercial experience in the pharmaceutical industry

• Proven business acumen and brand management expertise

• Excellent communication and presentation skills